BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 3101610)

  • 21. [Combined treatment of hypopharyngeal carcinoma].
    Düring A; Sauer R; Steiner W; Herbst M; Reul H
    Strahlenther Onkol; 1987 Dec; 163(12):764-73. PubMed ID: 3424076
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advanced hypopharyngeal cancer with amyotrophic lateral sclerosis.
    Kogashiwa Y; Oishi N; Yamauchi K; Kohno N
    Auris Nasus Larynx; 2011 Dec; 38(6):750-2. PubMed ID: 21333475
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of hypopharyngeal carcinoma: a 10-year review of 1,362 cases.
    Pingree TF; Davis RK; Reichman O; Derrick L
    Laryngoscope; 1987 Aug; 97(8 Pt 1):901-4. PubMed ID: 3613786
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Urinary bladder metastasis--an unusual presentation of distant spread from a primary pyriform sinus cancer: a case report.
    Walvekar RR; Pantvaidya GH; Desai SB; Chaukar DA; D'Cruz AK
    Auris Nasus Larynx; 2006 Dec; 33(4):493-5. PubMed ID: 16920307
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phase I trial of twice-weekly intravenous interleukin 12 in patients with metastatic renal cell cancer or malignant melanoma: ability to maintain IFN-gamma induction is associated with clinical response.
    Gollob JA; Mier JW; Veenstra K; McDermott DF; Clancy D; Clancy M; Atkins MB
    Clin Cancer Res; 2000 May; 6(5):1678-92. PubMed ID: 10815886
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pelvic metastasis in a patient with hypopharyngeal SCC.
    Esfandiari K; Tavakoli H; Rezaii J; Khashayar P
    Otolaryngol Head Neck Surg; 2009 Dec; 141(6):792-3. PubMed ID: 19932859
    [No Abstract]   [Full Text] [Related]  

  • 27. Multidisciplinary treatment of carcinoma of oropharynx and hypopharynx: principles and EORTC studies.
    Snow GB
    Sonderb Strahlenther Onkol; 1987; 81():127-34. PubMed ID: 3547724
    [No Abstract]   [Full Text] [Related]  

  • 28. [Clinical analysis of posterior hypopharyngeal wall squamous cell carcinoma: a report of 36 cases].
    Wang JH; Qi YF; Tang PZ; Wen SX; Zhang ZM; Qin DX
    Ai Zheng; 2005 Sep; 24(9):1106-10. PubMed ID: 16159434
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypopharyngeal squamous cell carcinoma in a child.
    Köksal Y; Varan A; Hoşal S; Büyükpamukçu M
    Int J Pediatr Otorhinolaryngol; 2005 Jul; 69(7):989-91. PubMed ID: 15911020
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical study of the sentinel lymph node of patients with laryngeal and hypopharyngeal carcinomas].
    Fang J; Wei X; Li S; Wang C; Tian A; Tao Y; Sun X; Zou S; Li M; Cai S; Luan X
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2001 Aug; 36(4):244-6. PubMed ID: 12761986
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Interferon (IFN) therapy (recombinant IFN-alpha-2C or recombinant IFN-gamma) in metastasized hypernephroma].
    Kuzmits R; Scheithauer W; Ludwig H; Flener R
    Acta Med Austriaca; 1985; 12(5):129-34. PubMed ID: 3938590
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypopharyngeal squamous cell carcinoma producing both granulocyte colony-stimulating factor and parathyroid hormone-related protein.
    Tamura K; Yoshinaga T; Tanino M; Kimura T; Yamada N; Nishimura M; Fukuda S; Nishihara H; Shindoh M; Tanaka S
    Pathol Int; 2008 Oct; 58(10):652-6. PubMed ID: 18801086
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A phase I trial of recombinant human gamma interferon (IFN-gamma 4A) in patients with advanced malignancy.
    Perez R; Lipton A; Harvey HA; Simmonds MA; Romano PJ; Imboden SL; Giudice G; Downing MR; Alton NK
    J Biol Response Mod; 1988 Jun; 7(3):309-17. PubMed ID: 3134513
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Phase I study of natural interferon-gamma].
    Furue H; Urushizaki I; Wakui A; Nagai M; Toriyama S; Niitani H; Osamura S; Ishihara K; Sato H; Taguchi T
    Gan To Kagaku Ryoho; 1987 Aug; 14(8):2537-41. PubMed ID: 3113341
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Combination therapy of hypopharyngeal cancer].
    Miyahara H
    Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 1):1804-11. PubMed ID: 3592715
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Treatment of nasopharyngeal cancer with recombinant gamma interferon (IFN). A report based on 2 patients].
    Zanetti F; Elies S
    Laryngol Rhinol Otol (Stuttg); 1987 Jan; 66(1):54-6. PubMed ID: 3104706
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Results of low dosage cyclic interferon-gamma therapy of metastatic renal cell carcinoma].
    Hofmockel G; Wirth MP; Heimbach D; Frohmüller HG
    Urologe A; 1993 Jul; 32(4):290-4. PubMed ID: 8372410
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A case of neck metastasis from hypopharyngeal carcinoma successfully treated with TS-1].
    Kajikawa H; Nario K; Miyahara H
    Gan To Kagaku Ryoho; 2004 Apr; 31(4):631-4. PubMed ID: 15114715
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phase I trial of recombinant macrophage colony-stimulating factor and recombinant gamma-interferon: toxicity, monocytosis, and clinical effects.
    Weiner LM; Li W; Holmes M; Catalano RB; Dovnarsky M; Padavic K; Alpaugh RK
    Cancer Res; 1994 Aug; 54(15):4084-90. PubMed ID: 8033141
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Determination of prognosis-relevant factors in patients with hypo- or oropharyngeal carcinoma].
    Esser D; Meyer W; Willgeroth C; Motsch C
    HNO; 1994 Jul; 42(7):413-7. PubMed ID: 7928431
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.